Garen G Bohlin - Net Worth and Insider Trading
Garen G Bohlin Net Worth
The estimated net worth of Garen G Bohlin is at least $2 Million dollars as of 2024-12-29. Garen G Bohlin is the Director of Collegium Pharmaceutical Inc and owns about 52,468 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $2 Million. Garen G Bohlin is also the Director of Karyopharm Therapeutics Inc and owns about 45,140 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $31,643. Details can be seen in Garen G Bohlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Garen G Bohlin has not made any transactions after 2024-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Garen G Bohlin
Garen G Bohlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Garen G Bohlin owns 5 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Collegium Pharmaceutical Inc (COLL) , and Tetraphase Pharmaceuticals Inc (TTPH) among others .
Click here to see the complete history of Garen G Bohlin’s form 4 insider trades.
Insider Ownership Summary of Garen G Bohlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2023-09-12 | director |
| COLL | Collegium Pharmaceutical Inc | 2024-05-14 | director |
| TTPH | Tetraphase Pharmaceuticals Inc | 2019-06-10 | director |
 | | 2014-10-21 | director |
| | 2009-01-02 | director |
Garen G Bohlin Latest Holdings Summary
Garen G Bohlin currently owns a total of 2 stocks. Among these stocks, Garen G Bohlin owns 52,468 shares of Collegium Pharmaceutical Inc (COLL) as of May 14, 2024, with a value of $2 Million and a weighting of 97.97%. Garen G Bohlin also owns 45,140 shares of Karyopharm Therapeutics Inc (KPTI) as of September 12, 2023, with a value of $31,643 and a weighting of 2.03%.
Latest Holdings of Garen G Bohlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2024-05-14 | 52,468 | 29.11 | 1,527,343 |
| KPTI | Karyopharm Therapeutics Inc | 2023-09-12 | 45,140 | 0.70 | 31,643 |
Holding Weightings of Garen G Bohlin
Garen G Bohlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Garen G Bohlin has made a total of 1 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 28,985 shares on May 14, 2024, which brought Garen G Bohlin around $936,216.
According to the SEC Form 4 filings, Garen G Bohlin has made a total of 2 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Karyopharm Therapeutics Inc is the acquisition of 41,140 shares on September 12, 2023, which cost Garen G Bohlin around $50,191.
Insider Trading History of Garen G Bohlin
- 1
Garen G Bohlin Trading Performance
GuruFocus tracks the stock performance after each of Garen G Bohlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Garen G Bohlin is -37.36%. GuruFocus also compares Garen G Bohlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Garen G Bohlin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Garen G Bohlin's insider trading performs compared to the benchmark.
Performance of Garen G Bohlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.49 | | | | | |
| Relative Return to S&P 500(%) | 4.41 | | | | | |
Garen G Bohlin Ownership Network
Garen G Bohlin Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Garen G Bohlin is the director of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Garen G Bohlin made 1 insider transaction in Karyopharm Therapeutics Inc (KPTI) with a net purchase of 41,140. Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,766 shares made by Richard A. Paulson , a net sale of 55,214 shares made by Michael Mason , and a net sale of 34,041 shares made by Stuart Poulton .
In summary, during the past 3 months, insiders sold 10,902 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 10,902 shares. During the past 18 months, 2,075,796 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,034,656 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Garen G Bohlin Mailing Address
Above is the net worth, insider trading, and ownership report for Garen G Bohlin. You might contact Garen G Bohlin via mailing address: C/o Praecis Pharmaceuticals Inc, 830 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
